» Articles » PMID: 36680200

Anti-Entry Activity of Natural Flavonoids Against SARS-CoV-2 by Targeting Spike RBD

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Jan 21
PMID 36680200
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 is still a global public health concern, and the SARS-CoV-2 mutations require more effective antiviral agents. In this study, the antiviral entry activity of thirty-one flavonoids was systematically evaluated by a SARS-CoV-2 pseudovirus model. Twenty-four flavonoids exhibited antiviral entry activity with IC values ranging from 10.27 to 172.63 µM and SI values ranging from 2.33 to 48.69. The structure-activity relationship of these flavonoids as SARS-CoV-2 entry inhibitors was comprehensively summarized. A subsequent biolayer interferometry assay indicated that flavonoids bind to viral spike RBD to block viral interaction with ACE2 receptor, and a molecular docking study also revealed that flavonols could bind to Pocket 3, the non-mutant regions of SARS-CoV-2 variants, suggesting that flavonols might be also active against virus variants. These natural flavonoids showed very low cytotoxic effects on human normal cell lines. Our findings suggested that natural flavonoids might be potential antiviral entry agents against SARS-CoV-2 inactivating the viral spike. It is hoped that our study will provide some encouraging evidence for the use of natural flavonoids as disinfectants to prevent viral infections.

Citing Articles

Diverse Structures of Tea Polyphenols from Rougui Wuyi Rock Tea and Their Potential as Inhibitor of 3C-like Protease.

Sun Q, Chen X, Zhang J, Song J, Yao L, Zhao Y Molecules. 2025; 30(5).

PMID: 40076249 PMC: 11901911. DOI: 10.3390/molecules30051024.


Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking.

Gupta G, Verkhivker G Int J Mol Sci. 2024; 25(9).

PMID: 38732174 PMC: 11084335. DOI: 10.3390/ijms25094955.


Natural products as a source of Coronavirus entry inhibitors.

Szabo D, Crowe A, Mamotte C, Strappe P Front Cell Infect Microbiol. 2024; 14:1353971.

PMID: 38449827 PMC: 10915212. DOI: 10.3389/fcimb.2024.1353971.


Chemical Compositions of Georgi. (Huangqin) Extracts and Their Effects on ACE2 Binding of SARS-CoV-2 Spike Protein, ACE2 Activity, and Free Radicals.

Gao B, Zhu H, Liu Z, He X, Sun J, Li Y Int J Mol Sci. 2024; 25(4).

PMID: 38396723 PMC: 10888547. DOI: 10.3390/ijms25042045.


Development of SARS-CoV-2 entry antivirals.

Dong M, Galvan Achi J, Du R, Rong L, Cui Q Cell Insight. 2024; 3(1):100144.

PMID: 38323318 PMC: 10844678. DOI: 10.1016/j.cellin.2023.100144.


References
1.
Alzaabi M, Hamdy R, Ashmawy N, Hamoda A, Alkhayat F, Khademi N . Flavonoids are promising safe therapy against COVID-19. Phytochem Rev. 2021; 21(1):291-312. PMC: 8139868. DOI: 10.1007/s11101-021-09759-z. View

2.
Solopov P, Colunga Biancatelli R, Dimitropoulou C, Catravas J . Dietary Phytoestrogens Ameliorate Hydrochloric Acid-Induced Chronic Lung Injury and Pulmonary Fibrosis in Mice. Nutrients. 2021; 13(10). PMC: 8536981. DOI: 10.3390/nu13103599. View

3.
Bardelcikova A, Mirossay A, Soltys J, Mojzis J . Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy. Phytother Res. 2022; 36(5):2042-2060. PMC: 9111001. DOI: 10.1002/ptr.7436. View

4.
Bongini P, Trezza A, Bianchini M, Spiga O, Niccolai N . A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization. Biochem Biophys Res Commun. 2020; 528(1):35-38. PMC: 7144664. DOI: 10.1016/j.bbrc.2020.04.007. View

5.
Liu H, Ye F, Sun Q, Liang H, Li C, Li S . extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease . J Enzyme Inhib Med Chem. 2021; 36(1):497-503. PMC: 7850424. DOI: 10.1080/14756366.2021.1873977. View